Old Web
English
Sign In
Acemap
>
authorDetail
>
Jean A van Wyk
Jean A van Wyk
Research Triangle Park
Medicine
Dolutegravir
Intensive care medicine
Internal medicine
Raltegravir
4
Papers
10
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Improvement in Metabolic Health Parameters at Week 48 After Switching From a Tenofovir Alafenamide-Based 3- or 4-Drug Regimen to the 2-Drug Regimen of Dolutegravir/Lamivudine: The TANGO Study
2021
Journal of Acquired Immune Deficiency Syndromes
Jean A van Wyk
Mounir Ait-Khaled
Jesús Santos
Stefan Scholten
Michael Wohlfeiler
Faiza Ajana
Bryn Jones
M. Nascimento
Allan R. Tenorio
Don Smith
Jonathan Wright
Brian Wynne
Show All
Source
Cite
Save
Citations (1)
978. Changes in BMI Associated with Antiretroviral Regimens in Treatment-Experienced, Virologically Suppressed Individuals Living with HIV
2019
Open Forum Infectious Diseases
Karam Mounzer
Laurence Brunet
Ricky Hsu
Terra Fatukasi
Jennifer S Fusco
Vani Vannappagari
Cassidy Henegar
Jean A van Wyk
Melissa Crawford
Janet Lo
Gregory Fusco
Show All
Source
Cite
Save
Citations (5)
2484. Patient Reported Outcomes After Switching to a 2-Drug Regimen of Dolutegravir + Rilpivirine: Week 148 Results from the Sword-1 and Sword-2 Studies
2019
Open Forum Infectious Diseases
Alan Oglesby
Kostas Angelis
Yogesh Punekar
Vasiliki Chounta
Antonio Antela
Jessica E. Matthews
Lesley Kahl
Martin Gartland
Brian Wynne
Miranda Murray
Jean A van Wyk
Show All
Source
Cite
Save
Citations (3)
341. Risk of Type 2 Diabetes Mellitus after Antiretroviral Therapy Initiation in Individuals Living with HIV in the United States
2019
Open Forum Infectious Diseases
Ricky Hsu
Laurence Brunet
Jennifer S Fusco
Karam Mounzer
Vani Vannappagari
Cassidy Henegar
Jean A van Wyk
Lloyd Curtis
Janet Lo
Gregory Fusco
Show All
Source
Cite
Save
Citations (1)
1
map